High expression of cathepsin B has been detected in a variety of tumor tissues including primary cutaneous melanoma and the serum of tumor patients (Fröhlich et al., 2001) and can be used as one of the melanoma serum biomarkers (Zhang et al., 2011). Here, CTSB is linked to neoplasm.